Change Reporting Category Advisor
Rate a proposed post-approval CMC change across quality impact, established-conditions status, comparability, and precedent to get a likely reporting-category band — prior-approval, moderate notification, or low/annual — as a triage aid. Aligned to ICH Q12 and ICH Q9(R1); the binding category is set by the regional framework.
OUTPUT
TIME
Limitations — read before you rely on this
- The output is explicitly an aid, not a filing determination; the binding category is set by the region’s framework and your approved dossier/PACMP, which this tool does not read.
- The point scheme and cut-points are SPEQ’s heuristic and cannot capture region-specific rules, product-specific commitments, or negotiated PACMP terms.
- This calculator is transparent but it is not a validated system, and it must never substitute for a regulatory-affairs assessment of the actual change.
- Reproduce the classification in your own qualified system and confirm it with regulatory affairs against the applicable regional guidance before any change is filed.
WHAT THIS CALCULATES
Suggests a likely post-approval CMC change reporting-category band — from prior-approval through moderate notification to low/annual — as a decision aid, from the change’s quality impact, established-conditions status, comparability, and precedent.
THE METHOD
Tier_score = Σ factor_points Band = Prior-Approval ≥6 · Moderate 3–5 · Low ≤2- Tier_score
- The summed points across the four judgment factors; higher means higher likely regulatory scrutiny.
- factor_points
- The points contributed by each factor (quality impact, established-conditions status, comparability, precedent), each 0–2.
- Band
- The suggested reporting-category band the score maps to (Prior-Approval / Moderate-Notification / Low-or-Annual-Report).
The point scheme and cut-points are a SPEQ decision-aid heuristic, not a regulatory algorithm. ICH Q12 establishes established conditions and the reporting-category concept, but the actual category is set by each region’s framework (FDA 21 CFR 314.70: PAS / CBE-30 / CBE-0 / annual report; EU variations Type IA/IB/II) and the product’s approved dossier and any PACMP.
THE INPUTS, AND WHAT THEY MEAN
- Quality-attribute impact
- The assessed effect of the change on critical quality attributes, safety, or efficacy — from none/negligible through moderate to significant/potentially adverse. The dominant driver.
- Established conditions
- Whether the change stays outside established conditions or is managed under an approved PACMP (lower burden) versus changing an established condition (higher).
- Comparability
- Whether post-change material is demonstrated comparable to pre-change on the attributes the change actually puts at risk.
- Precedent / guidance
- Whether an applicable guidance, monograph, or accepted precedent classifies this change type, versus a novel change with no established route.
What reporting category is a CMC change likely to need?
Rate a proposed post-approval change across four factors. SPEQ suggests a likely reporting-category band — prior-approval, moderate notification, or low/annual — as a triage aid. The binding category is always set by the region’s framework and your approved dossier, so run it per region.
HOW TO READ THE OUTPUT
- The band is a SPEQ decision aid, not a filing category; the binding category comes from the specific regional framework and the product’s approved dossier/PACMP, and only regulatory affairs determines the actual filing.
- The established-conditions status is pivotal: ICH Q12’s central mechanism is that changes to non-ECs, or changes managed under an approved PACMP, carry a lower reporting burden — so this input can move the band more than the others.
- A favourable comparability result lowers scrutiny only if it addresses the attributes the change actually endangers; comparability on the wrong attributes does not de-risk the change.
- Regional divergence is real — the same change can be a prior-approval supplement in one region and a lower category in another — so run it per region and never read a single band as globally valid.
WORKED EXAMPLE
A manufacturer proposes tightening an in-process control limit already described in the approved application.
- Quality impact
- negligible (0)
- Established conditions
- non-EC parameter (0)
- Comparability
- not applicable (0)
- Precedent
- well-established (0)
RESULT
A low-impact, in-EC, precedented change points toward the lowest reporting tier — but regulatory affairs must still confirm it against the region’s framework and the specific dossier before filing it that way.
REGULATORY BASIS
- ICH Q12 Product Lifecycle Management
- Defines established conditions, reporting categories, and PACMPs — the framework this aid operationalises.
- ICH Q9(R1) Quality Risk Management
- Provides the risk-assessment basis for judging a change’s impact on quality attributes.
- FDA 21 CFR 314.70 / EU Variations Regulation
- Set the actual, binding reporting categories (PAS/CBE/annual report; Type IA/IB/II) the band only approximates.